These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2605580)

  • 1. [Gallopamil and chlorthalidone versus atenolol and chlorthalidone in the treatment of obstructive hypertrophic cardiomyopathy in patients with arterial hypertension: polycardiographic evaluation of the systolic and diastolic function of the left ventricle].
    Chieppa S; Lobascio C; Brandini V; Iarussi D; Giuliani F; Langella S; De Simone R
    Cardiologia; 1989 Aug; 34(8):695-9. PubMed ID: 2605580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in blood pressure and thermographic values resulting from use of a beta-blocker plus diuretic and of an alpha-beta-blocker plus diuretic.
    De Cesaris R; Grimaldi A; Balestrazzi M; Ranieri G; Chiarappa R; Avantaggiato F
    Drugs Exp Clin Res; 1985; 11(10):725-9. PubMed ID: 3836858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmarketing survey of the effects of an atenolol/chlorthalidone combination in the treatment of hypertension.
    Maxwell MH; Garrett BN; Saunders E; Schnaper H
    Clin Ther; 1987; 9(4):380-9. PubMed ID: 3607820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients.
    Fogari R; Zoppi A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):386-93. PubMed ID: 6469428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regression of left ventricular mass in arterial hypertension. Efficacy of 3 different treatment protocols].
    González-Juanatey JR; Amaro Cendón A; Calvo Gómez C; Vega Fernández M; García Acuña JM; Virgós Lamela A; Gil de la Peña M
    Med Clin (Barc); 1992 Mar; 98(11):401-4. PubMed ID: 1533259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
    Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A
    Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
    Holzgreve H; Nakov R; Beck K; Janka HU
    Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination].
    Brandstetter G; Hoffmann H
    Wien Klin Wochenschr; 1984 Sep; 96(18):696-9. PubMed ID: 6240831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systolic-diastolic function of the left ventricle and flowmetry of the lower limbs in the treatment of moderate essential arterial hypertension with atenolol-chlorthalidone].
    Franchi F; Bisi G; Fabbri G; Pedenovi P; Lo Sapio P; Matassi L; Righi D; Galanti G
    Minerva Cardioangiol; 1986 Sep; 34(9):567-77. PubMed ID: 3543732
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diastolic ventricular function in hypertrophic, obstructive and non-obstructive cardiomyopathy--effect of gallopamil].
    Olbrich HG; Hopf R; Klepzig H; Hör G; Maul FD; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 5():29-35. PubMed ID: 2631478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study.
    Pareek A; Karnik N; Salagre SB; Zawar SD; Joglekar VK; Chandurkar N; Naik GS
    Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Normalization of ventricular compliance and hypertrophy in arterial hypertension. Double-blind study with 2 combinations of a beta blocker and diuretic].
    Mohallen KL; do Patrocínio LL; Célnik D; Kruczan DD; Pinheiro L; Weitzel LH; Bosco J; Sekeff JA; Azevedo Ade C
    Arq Bras Cardiol; 1987 Jun; 48(6):345-50. PubMed ID: 2965568
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term effect of antihypertensive therapy on left ventricular hypertrophy.
    Franz IW; Tönnesmann U; Behr U; Ketelhut R
    J Hypertens Suppl; 1987 Dec; 5(5):S415-8. PubMed ID: 2965229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of atenolol (Tenormin) and the combined preparation atenolol/chlorthalidone (Tenoretic Mite) in essential hypertension. A randomized double-blind study from general practice].
    Pilgaard S; Palmelund VO; Svendsen TL
    Ugeskr Laeger; 1990 Apr; 152(15):1083-6. PubMed ID: 2184556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose atenolol-chlorthalidone combination for treatment of mild hypertension.
    Leonetti G; Pasotti C; Capra A
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):43-7. PubMed ID: 3514487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Left ventricular systolic and diastolic functions in hypertrophic cardiomyopathy: with special reference to clinical symptom and the effects of calcium blocking agent (nifedipine)].
    Yamakado T; Higashiyama S; Nakano T; Takezawa H
    J Cardiol Suppl; 1987; 16():53-63. PubMed ID: 3509683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians.
    Salako LA; Falase AO; Aderounmu AF; Walker O
    Afr J Med Med Sci; 1990 Mar; 19(1):57-61. PubMed ID: 2109522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical profile of hypertensive patients can predict the need for combining a second or third drug with atenolol in the initial treatment of light and moderate essential arterial hypertension].
    Coca A; de la Sierra A; Sobrino J; Aguilera MT; Lluch MM; Sánchez M; Picado MJ; Urbano-Márquez A
    Med Clin (Barc); 1990 Sep; 95(9):329-32. PubMed ID: 2280617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.